Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cysteine-rich proteins (CRPs) are a large and diverse class of proteins and peptides present in all living organisms, characterized by a high content of cysteine residues. These cysteines commonly form intra- or intermolecular disulfide bonds, or chelate metal ions, resulting in a stable tertiary structure. CRPs fulfill a wide range of biological functions, most notably as extracellular signals, hormones, growth factors, enzyme inhibitors, ion channel modulators, and antimicrobial peptides. Major subfamilies include cysteine-rich secretory proteins (CRISPs), cysteine-rich intestinal proteins (CRIPs), defensins, knottins, and others, each with distinct physiological roles. Members of this class can be involved in immune response, reproductive processes, embryonic development, angiogenesis, and cancer, but "cysteine-rich proteins" as a term does not denote a single drug target and is too broad for direct therapeutic manipulation; instead, individual proteins from these families may serve as significant disease markers, targets, or therapeutic scaffolds.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cysteine-rich proteins.